The Hebron® Research and Development Center incorporates one of the best equipped quality control laboratories in the country. This center operates in the several phases of research, including clinical and pre-clinical studies which ensure that the products reach the market with the scientific approval and technical rigor demanded by the health authorities and laws in force in the country.
However, with highly qualified professionals, with PhD, Masters and Graduated in areas such as Pharmacy, Biology, Chemistry, among others, Hebron® has also a Board of Research, Development and Innovation which is in charge of the pre-established pipeline and Technological Innovation of the already-existing products, developing medicines with the necessary efficacy and safety.
Simultaneously, the Center maintains a close cooperation with renowned Federal Universities (Ceará, Rio Grande do Norte, Paraíba, Pernambuco, Alagoas, Bahia, Rio de Janeiro and São Paulo) and State Universities (UPE, USP and UNICAMP), and develops projects in partnership with international research institutions, serving on the constant search for therapeutic alternatives for several diseases.
Florax has been developed in a research center in France, from yeast, Saccharomyces cerevisiae, which offers a better alternative treatment for the replacement of intestinal macrobiota. The medicine provides the live strain, in a buffered medium, which gives it a much higher performance than that of the lyophilized products.